Who made the gains in October? Here are the top ASX resources winners
From petri dishes to pharma giants, Clever Culture’s AI goes global
Health Food Symmetry eyes public debut with $2 million raise to shake up gut health market
Closing Bell: ASX fends off losses in resources and tech with defensive rotation
Resources Top 5: Mont Royal makes strong return to the boards after landing Canadian rare earths play
Health Check: Our flu recovery prognosis is positive, CSL tells investors
Top cyber scientist warns of quantum computing security threats
Biocurious: Buoyed by capital raisings, biotechs storm home with a wet sail
Lunch Wrap: Rare earths tumble and tech rattled as the Big Short returns
Silver tsunami wave captures 700,000 retirees in super tax trap
Contributors
Our Resident Experts
Mining
Who made the gains in October? Here are the top ASX resources winners
Resources Top 5: Mont Royal makes strong return to the boards after landing Canadian rare earths play
Resources Top 5: Investors look to back a winning horse as Richardson Street Group gets De Grey band back together
Up, Up, Down, Down: Gold hit a record but will we look back on October as lithium’s turning point?
Resources Top 5: Investors rush to board the Mount Ridley gallium train
Featured in Mining
Tech
ASX Tech October Winners: Sector buckles under Xero and WiseTech, but Weebit joins $1bn club
ASX Quarterly Tech Wrap: Acquisitions, deals and capital raises
The biometric edge: Can algorithms help you crack the three-hour marathon?
Air traffic bombarded by cyber criminals every day
Back Australia: We either innovate, or we will stagnate … it’s that simple
Featured in Tech
Health & Biotech
Health Check: Our flu recovery prognosis is positive, CSL tells investors
Biocurious: Buoyed by capital raisings, biotechs storm home with a wet sail
ASX Health October Winners: When CSL sneezes, sector catches flu
ASX Health Quarterly Wrap: Progress on multiple fronts in strong start to FY26
Health Check: Biotechs canter into November, but the ‘favourites’ have lead in their saddlebags
Featured in Health & Biotech
Experts
How the cheapest ETF investment strategy is minting millionaires
Reasons why inflation is high and an interest rate cut is off the table for the RBA
Stock Tips: Energy, property and F1-fuelled momentum drive this week’s picks
Criterion: In fostering truly sustainable investments, ELM waters the flowers and not the weeds
How to follow Rinehart’s lead and play the critical minerals boom
Clever or crazy? How to crack the airline status game with one flight
Is Jerome Powell’s likely rate cut pause a warning?
